Pharma Resource Group Revenue and Competitors

Havertown, PA USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Pharma Resource Group's estimated annual revenue is currently $12.5M per year.(i)
  • Pharma Resource Group's estimated revenue per employee is $201,000

Employee Data

  • Pharma Resource Group has 62 Employees.(i)
  • Pharma Resource Group grew their employee count by 29% last year.

Pharma Resource Group's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$43.2M2156%N/AN/A
#2
$81.8M40710%N/AN/A
#3
$11.7M580%N/AN/A
#4
$1011.8M5034-9%N/AN/A
#5
$44.8M2231%N/AN/A
#6
$13.1M655%N/AN/A
#7
$16.5M8241%N/AN/A
#8
$17.3M86-5%N/AN/A
#9
$67.9M33823%N/AN/A
#10
$14.9M747%N/AN/A
Add Company

What Is Pharma Resource Group?

Pharma Resource Group, Inc. (PRG) is a full-service pharmaceutical resource and services provider. PRG provides strategic and tactical solutions for the ethical pharmaceutical, OTC, nutraceutical and biotech industries that are scientifically based and built upon three distinct characteristics: Expertise — scientific rationale with innovative and logical thinking Knowledge — people, process and products Execution — unique, unprecedented flexibility to respond to the clients' wants and needs Apply ground-floor approach to gaining a practical and comprehensive understanding of our clients' requirements, people, products, processes and technology. Fulfill client and regulatory requirements by employing a well-planned, logical approach in all phases of an engagement, development through commercialization. Create scalable solutions for our clients' needs utilizing industry expertise and practical experience with practices, standards and compliance requirements.

keywords:N/A

N/A

Total Funding

62

Number of Employees

$12.5M

Revenue (est)

29%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$13.4M895%N/A
#2
$3.5M964%N/A
#3
$31M1076%N/A
#4
$30.2M15715%N/A
#5
$72.1M3987%N/A